Autoimmune disease symptoms vary greatly depending on which part of the body is affected, but some common symptoms include ...

SEOUL, South Korea I June 02, 2025 I ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S.

The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.

Company to host conference call and webcast on June 9, 2025, at 8:00 a.m. ETSAN FRANCISCO and VANCOUVER, British Columbia, ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Antibody discovery, crucial for developing targeted therapies in fields like oncology and autoimmune diseases, is evolving ...

Researchers show that analyzing the 3D shapes of antibodies, not just their genetic sequences, can better group functionally ...